How Pfizer Crafted Its Own ‘Operation Warp Speed’ For The COVID-19 Vaccine
Final Leg Of Supply Talks With Indian Govt
It’s counter-intuitive, but not signing a commercial contract with BioNTech and refusing US federal funding were two of several moves Pfizer made to speed up development of its COVID-19 vaccine, CEO Albert Bourla says. Now it’s looking to supply low- and middle-income countries.
